n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide and Anemia, Sickle Cell

n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide has been researched along with Anemia, Sickle Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Burnett, AL; Chen, H; Karakus, S; La Favor, JD; Musicki, B; Silva, FH; Sturny, M; Zirkin, BR	1

Other Studies

1 other study(ies) available for n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide and Anemia, Sickle Cell

Article	Year
TSPO ligand FGIN-1-27 controls priapism in sickle cell mice via endogenous testosterone production. Journal of cellular physiology, 2021, Volume: 236, Issue:4 Topics: Anemia, Sickle Cell; Animals; Cyclic Nucleotide Phosphodiesterases, Type 5; Humans; Indoleacetic Acids; Luteinizing Hormone; Male; Mice, Transgenic; NADPH Oxidases; Nitric Oxide; Penis; Phosphorylation; Priapism; Receptors, GABA; Testis; Testosterone; Tyrosine	2021

Article

Year

TSPO ligand FGIN-1-27 controls priapism in sickle cell mice via endogenous testosterone production.

Journal of cellular physiology, 2021, Volume: 236, Issue:4

Topics: Anemia, Sickle Cell; Animals; Cyclic Nucleotide Phosphodiesterases, Type 5; Humans; Indoleacetic Acids; Luteinizing Hormone; Male; Mice, Transgenic; NADPH Oxidases; Nitric Oxide; Penis; Phosphorylation; Priapism; Receptors, GABA; Testis; Testosterone; Tyrosine

2021